Recce Pharmaceuticals Eulerpool Uudised

Recce Pharmaceuticals aktsia uudised

Recce Pharmaceuticals jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Recce Pharmaceuticals uudised paneme siia kokku.

• 1. detsember ·

  Yahoo
  Investors in Recce Pharmaceuticals (ASX:RCE) have seen notable returns of 68% over the past five years
• 27. november ·

  Yahoo
  Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives
• 12. november ·

  Yahoo
  Recce Pharmaceuticals Receives Ethics Approval in Indonesia to Commence Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
• 6. november ·

  Yahoo
  Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
• 10. oktoober ·

  Yahoo
  Recce Pharmaceuticals Announces Recruitment Passes Halfway in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
• 6. august ·

  Yahoo
  Recce Pharmaceuticals Announces Successful Completion of Share Purchase Plan
• 10. juuli ·

  Yahoo
  Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
• 1. juuli ·

  Yahoo
  Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327
• 25. juuni ·

  Yahoo
  Recce Pharmaceuticals Receives Ethics Approval to Broaden RECCE® 327 Gel Trials Across all Topical Bacterial Skin Infections
• 20. juuni ·

  Yahoo
  Recce Pharmaceuticals Announces Addition of RECCE® 327 to The World Health Organization’s List of Antibacterial Products in Clinical Development